MAPK3 and cervical carcinoma: Interestingly, our results of the p-Erk1/2 protein level in solamargine-treated cervical cancer cells were consistent with those of the former, which prompted us to presume that perhaps solamargine could modulate the Erk signaling pathway in cervical cancer.